============
Arix Bioscience PLC (ARIX)
Unaudited NAV for October 2022
09-Nov-2022 / 07:00 GMT/BST
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════
Arix Bioscience plc
Unaudited NAV for October 2022
LONDON, 9 November 2022: Arix Bioscience plc (“Arix” or the “Company”)
(LSE: ARIX), a global venture capital company focused on investing in
breakthrough biotechnology companies, announces the unaudited Net Asset
Value (“NAV”) of the Company for the date ended 31 October 2022 as
follows:
NAV Breakdown
Total
Date Listed Other NAV NAV
Portfolio Unlisted Portfolio Cash Interests per
share
31 October 22
£46.6 £57.6 £129.2m £2.0m £235.4m £1.82
(unaudited)
ENDS
Enquiries
For more information on Arix, please contact:
Arix Bioscience plc
+44 (0)20 7290 1050
ir 1 @arixbioscience.com
Powerscourt Group
Sarah MacLeod, Ibrahim Khalil, Nick Johnson
+44 (0)20 7250 1446
2 arix@powerscourt-group.com
About Arix Bioscience plc
Arix Bioscience plc is a global venture capital company focused on
investing in breakthrough biotechnology companies around cutting-edge
advances in life sciences.
We collaborate with exceptional entrepreneurs and provide the capital,
expertise, and global networks to help accelerate their ideas into
important new treatments for patients. As a listed company, we are able to
bring this exciting growth phase of our industry to a broader range of
investors. 3 www.arixbioscience.com
══════════════════════════════════════════════════════════════════════════
ISIN: GB00BD045071
Category Code: MSCM
TIDM: ARIX
LEI Code: 213800OVT3AHQCXNIX43
OAM Categories: 3.1. Additional regulated information required to be
disclosed under the laws of a Member State
Sequence No.: 199702
EQS News ID: 1482543
End of Announcement EQS News Service
══════════════════════════════════════════════════════════════════════════
4 fncls.ssp?fn=show_t_gif&application_id=1482543&application_name=news&site_id=reuters8
References
Visible links
1. mailto:charlotte@arixbioscience.com
2. mailto:arix@powerscourt-group.com
3. https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=889c637ce21c3a47a35c39202ebd9825&application_id=1482543&site_id=reuters8&application_name=news
============